Daily Archives: 13th June 2017

Chimerix reports excellent results from CMX157 Stage 1 clinical trial for HIV Chimerix.

Moch, Chief and President Executive Officer of Chimerix.’.. Chimerix reports excellent results from CMX157 Stage 1 clinical trial for HIV Chimerix, Inc., a pharmaceutical company developing orally-obtainable antiviral therapeutics, today announced first-in-human Phase 1 clinical trial results for CMX157 demonstrating a favorable safety, drug and tolerability distribution profile. Furthermore, results from a series of preclinical studies showed that CMX157 exhibited highly powerful in vitro activity against human being immunodeficiency virus , including HIV strains resistant to current treatments, and potent in vitro activity against xenotropic murine leukemia virus-related virus , a blood-borne retrovirus recently connected with chronic fatigue syndrome .D., Senior Director of Virology of Chimerix.’ ‘Our CMX001 and CMX157 programs are producing compelling clinical and preclinical evidence of how Chimerix’s PIM Conjugate Technology transforms the way compounds are absorbed, distributed, excreted and metabolized, creating new agents with improved antiviral action and reduced toxicities. Continue reading

Ameritox study shows correlation between positive marijuana exams.

Ameritox study shows correlation between positive marijuana exams, misuse of prescription drugs Ameritox, among the country's leaders in pain medicine monitoring, announced new analysis today showing a correlation between positive marijuana testing and higher rates of potential prescription medication non-adherence among chronic discomfort medication users lasixfurosemide.net lasixfurosemide.net . The research was shown at the American Academy of Discomfort Medicine annual meeting in Fort Lauderdale, Florida. During the period of twelve months, Ameritox studied more than a 100,000 urine samples from individuals nationwide who were prescribed hydrocodone, the most prescribed medication in the usa frequently, marketed under the names Vicodin, Lorcet, Lortab and others. Continue reading